ERBB3 and head and neck squamous cell carcinoma: Furthermore, although ESCC and SCCHN are considered to have frequent deregulation in HER2/HER3, we did not preselect patients with such aberrations, and patients with other downstream mutations or amplifications were not excluded (11 patients had PIK3CA mutation and six patients had PIK3CA gene amplification).